How to Buy Definium Therapeutics Stock
Definium Therapeutics Inc
Definium Therapeutics, Inc. is a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.
Definium Therapeutics stock last closed at $17.69, up 2.97% from the previous day, and has increased 191.43% in one year. It has overperformed other stocks in the Biotechnology industry by 2.05 percentage points. Definium Therapeutics stock is currently +276.38% from its 52-week low of $4.70, and -5.35% from its 52-week high of $18.69.
As of Mar 3, 2026, there are 99.7M shares of DFTX outstanding. The market value of DFTX is $1.76B. In the last 24 hours, 2.62M DFTX shares were traded.
How to Buy Definium Therapeutics Stock
Wondering how to invest in Definium Therapeutics stock? Here's how.
- Figure out where to buy Definium Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Definium Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your method of payment and add your details.
- Research Definium Therapeutics stock: The Definium Therapeutics ticker symbol is DFTX. Is Definium Therapeutics stock a good investment? Should you buy shares of DFTX? How do DFTX's underlying business fundamentals look? Do top analysts think Definium Therapeutics is a good buy? Why has DFTX's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if DFTX is a good stock to buy).
- Execute your DFTX purchase: Decide if you will purchase DFTX shares at the current market price or use a limit order to buy DFTX shares at a particular price.
- Keep tabs on your DFTX position: Create a watchlist to important notifications about your investment in Definium Therapeutics shares.
Step 1: Figure out where to buy Definium Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy DFTX stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal details so you can invest in DFTX stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have finished signing up on the highest rated stock app, you can securely and quickly fund your account:
Watch the walkthrough below if you need help depositing money into your brokerage account.
Step 4: Research Definium Therapeutics stock
Once you have chosen the best place to buy Definium Therapeutics stock, it's important to analyze their stock before you invest, so you can wrap your head around the risk and upside.
Definium Therapeutics shares quick numbers
Definium Therapeutics Overview
WallStreetZen was designed to help everyday investors do better fundamental analysis in less time.
You can see all of the due diligence checks on DFTX's stock page.
What is the fair value of DFTX stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge DFTX's fair value.
Using relative valuations metrics:
- DFTX could be overvalued based on its P/B ratio of 5.31x, relative to Biotechnology industry P/B ratio of 4.79x
You can access more valuation analysis on DFTX's stock here.
How do DFTX Financials look?
Signs that DFTX is financially healthy:
- There are more short-term assets than short-term liabilities on the DFTX balance sheet.
- DFTX has $411.59M in cash and short term investments. This is enough to cover its annual cash burn of $131.56M.
- DFTX has a low debt to equity ratio of 0.32.
- DFTX has cash burn of 131560000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the DFTX balance sheet.
Signs that DFTX is not financially healthy:
- Total DFTX debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy Definium Therapeutics stock
Out of 7 Wall Street analysts who research DFTX, the consensus analyst rating on DFTX is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Latest DFTX Analyst Upgrades/Downgrades
Sumant Kulkarni, a bottom 7% analyst from Canaccord Genuity maintains DFTX with a strong buy rating and raises their DFTX price target from $16.00 to $25.00, on Nov 7, 2025.
Ami Fadia, a top 1% analyst from Needham initiates coverage on DFTX with a buy rating and announces their DFTX price target of $28.00, on Oct 13, 2025.
You can dive deeper into what analysts are projecting on the Definium Therapeutics stock forecast page.
DFTX Technical Indicators
What are DFTX executives and large shareholders up to?
In the past 12 months, insiders at DFTX have sold more shares than they have bought.
Robert Barrow, Chief Executive Officer of DFTX, was the latest DFTX insider to sell. They sold $339,074.28 worth of DFTX shares on Dec 26, 2025.
Learn more about who owns DFTX stock here.
Does DFTX stock generate passive income?
No, Definium Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about DFTX?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your DFTX purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, use a limit order.
Click the Open Trade button and eToro will execute the order.
If you require more help investing in stocks on eToro, click the how to video below:
Step 6: Keep tabs on your DFTX position
Now that you own some DFTX shares, you'll want to keep up with your new investment.
Add DFTX to a watchlist to track the latest developments regarding your DFTX stock.
DFTX Feed
How to Buy Stock in Definium Therapeutics
To reiterate, here are the 6 steps to buy Definium Therapeutics stock:
- Figure out where to buy Definium Therapeutics stock
- Sign up for a brokerage account
- Fund your investment account
- Research Definium Therapeutics stock
- Execute your DFTX purchase
- Keep tabs on your DFTX position
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to watch your investment in Definium Therapeutics, create your watchlist below.
More Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.